OptiNose Inc (NASDAQ: OPTN) open the trading on Thursday, with great promise as it jumped 52.50% to $9.15, before settling in for the price of $6.00 at the close. Taking a more long-term approach, OPTN posted a 52-week range of $4.82-$26.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 22.26%. Meanwhile, its Annual Earning per share during the time was 34.78%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 40.83%. This publicly-traded company’s shares outstanding now amounts to $10.06 million, simultaneously with a float of $7.85 million. The organization now has a market capitalization sitting at $92.01 million. At the time of writing, stock’s 50-day Moving Average stood at $5.86, while the 200-day Moving Average is $10.63.
OptiNose Inc (OPTN) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Drug Manufacturers – Specialty & Generic industry. OptiNose Inc’s current insider ownership accounts for 21.94%, in contrast to 58.78% institutional ownership. According to the most recent insider trade that took place on Mar 18 ’25, this organization’s Chief Legal Officer & Corp Sec sold 246 shares at the rate of 5.61, making the entire transaction reach 1,380 in total value, affecting insider ownership by 55,038. Preceding that transaction, on Mar 18 ’25, Company’s Chief Executive Officer sold 368 for 5.61, making the whole transaction’s value amount to 2,064. This particular insider is now the holder of 126,563 in total.
OptiNose Inc (OPTN) Earnings and Revenue Records
OptiNose Inc’s EPS increase for this current 12-month fiscal period is 40.83% and is forecasted to reach -2.19 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 37.44% through the next 5 years, which can be compared against the 34.78% growth it accomplished over the previous five years trading on the market.
OptiNose Inc (NASDAQ: OPTN) Trading Performance Indicators
Let’s observe the current performance indicators for OptiNose Inc (OPTN). It’s Quick Ratio in the last reported quarter now stands at 0.72. The Stock has managed to achieve an average true range (ATR) of 0.69. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.22.
In the same vein, OPTN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.23, a figure that is expected to reach -0.74 in the next quarter, and analysts are predicting that it will be -2.19 at the market close of one year from today.
Technical Analysis of OptiNose Inc (OPTN)
[OptiNose Inc, OPTN] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 75.67% While, its Average True Range was 0.79.
Raw Stochastic average of OptiNose Inc (OPTN) in the period of the previous 100 days is set at 59.10%, which indicates a major fall in contrast to 90.00% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 183.82% that was higher than 119.17% volatility it exhibited in the past 100-days period.
